ISM1 | Isthmin 1, angiogenesis inhibitor | Predicted secreted proteins
| | | | | Tissue enhanced |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Transporters
| | | | | Tissue enhanced |
KCNIP3 | Kv channel interacting protein 3, calsenilin | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | | | | | | Tissue enhanced |
KIAA1658 | | | | | | | Tissue enhanced |
KLHL14 | Kelch-like family member 14 | | | | | | Tissue enhanced |
KLRG2 | Killer cell lectin-like receptor subfamily G, member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
KRT7 | Keratin 7 | Plasma proteins
| | | | | Tissue enhanced |
LCN12 | Lipocalin 12 | Predicted secreted proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
LRLE1 | Liver-related low express protein 1; Uncharacterized protein | | | | | | Tissue enhanced |
LRP1B | Low density lipoprotein receptor-related protein 1B | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRP8 | Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LURAP1 | Leucine rich adaptor protein 1 | | | | | | Tissue enhanced |
MARVELD2 | MARVEL domain containing 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
MCIDAS | Multiciliate differentiation and DNA synthesis associated cell cycle protein | | | | | | Tissue enhanced |
MEI4 | Meiosis-specific 4 homolog (S. cerevisiae) | Predicted secreted proteins
| | | | | Tissue enhanced |
MGAT4C | Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MPPED2 | Metallophosphoesterase domain containing 2 | | | | | | Tissue enhanced |
MROH2A | Maestro heat-like repeat family member 2A | | | | | | Tissue enhanced |
MT1F | Metallothionein 1F | | | | | | Tissue enhanced |
MT1G | Metallothionein 1G | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
MT1H | Metallothionein 1H | | | | | | Tissue enhanced |
MUC15 | Mucin 15, cell surface associated | Predicted membrane proteins
| | | | | Tissue enhanced |
NPNT | Nephronectin | Predicted secreted proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
OCA2 | Oculocutaneous albinism II | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
OR2W3 | Olfactory receptor, family 2, subfamily W, member 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PBX4 | Pre-B-cell leukemia homeobox 4 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
PDE10A | Phosphodiesterase 10A | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
PDE1A | Phosphodiesterase 1A, calmodulin-dependent | Enzymes
| | | | | Tissue enhanced |
PGF | Placental growth factor | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PKHD1L1 | Polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
PLEKHD1 | Pleckstrin homology domain containing, family D (with coiled-coil domains) member 1 | | | | | | Tissue enhanced |
PLEKHG4B | Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B | | | | | | Tissue enhanced |
PLEKHH1 | Pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
PPP1R14C | Protein phosphatase 1, regulatory (inhibitor) subunit 14C | | | | | | Tissue enhanced |
PRTG | Protogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAB43 | RAB43, member RAS oncogene family | | | | | | Tissue enhanced |
RAG1 | Recombination activating gene 1 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
RAP1GAP | RAP1 GTPase activating protein | | | | | | Tissue enhanced |
RAPGEF6 | Rap guanine nucleotide exchange factor (GEF) 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
RBMS3 | RNA binding motif, single stranded interacting protein 3 | | | | | | Tissue enhanced |
RGL3 | Ral guanine nucleotide dissociation stimulator-like 3 | | | | | | Tissue enhanced |
RGS16 | Regulator of G-protein signaling 16 | | | | | | Tissue enhanced |